Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Reset all filters
01 1ALAVERT
02 1ALPRAZOLAM
03 1ARICEPT ODT
04 1ARIPIPRAZOLE
05 2CARBIDOPA AND LEVODOPA
06 1CHILDRENS ALLEGRA ALLERGY
07 1CHILDRENS ALLEGRA HIVES
08 2CLONAZEPAM
09 1CLOZAPINE
10 1DONEPEZIL HYDROCHLORIDE
11 1FAZACLO ODT
12 1LAMOTRIGINE
13 1METOCLOPRAMIDE HYDROCHLORIDE
14 4MIRTAZAPINE
15 8OLANZAPINE
16 6ONDANSETRON
17 1PREDNISOLONE SODIUM PHOSPHATE
18 1REMERON SOLTAB
19 8RISPERIDONE
20 4RIZATRIPTAN BENZOATE
21 1STAXYN
22 3ZOLMITRIPTAN
23 1ZOMIG-ZMT
Reset all filters
01 121208
02 121231
03 121375
04 121590
05 121720
06 221909
07 176307
08 176534
09 176901
10 177171
11 177194
12 177243
13 177328
14 177376
15 177406
16 277494
17 177542
18 177557
19 178050
20 178088
21 178139
22 178152
23 178173
24 178464
25 178474
26 178690
27 178739
28 178893
29 190175
30 190469
31 190839
32 190881
33 191265
34 191537
35 1200179
36 1200221
37 1201824
38 1201914
39 1202102
40 1202179
41 1202191
42 1202285
43 1202476
44 1202560
45 1203708
46 1204320
47 1204336
48 1205798
49 1206382
50 1207835
Reset all filters
01 51No
02 1Yes


Drug : STAXYN
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 200179
Country : US
Patented : Yes
Drug : ONDANSETRON
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 78152
Country : US
Patented : No

Drug : LAMOTRIGINE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 206382
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : OLANZAPINE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 202285
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 78173
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : ONDANSETRON
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 78139
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : ALPRAZOLAM
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 78088
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : RISPERIDONE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 77494
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : RISPERIDONE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 77494
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : CLONAZEPAM
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 77171
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF


